LeMaitre Vascular, Inc. (LMAT)
Makes medical devices and grafts to repair damaged blood vessels and arteries.
$102.30+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+26.2%
The outlook
LeMaitre Vascular trades at $102.30, sitting well above both its 50- and 200-day moving averages and about 60% of the way through its 52-week range. Analysts lean bullish with a Buy consensus, and their average price target sits roughly 16% above the current price. The stock trades at a trailing P/E of 37.6, reflecting market expectations for growth.
What’s behind the score
Analyst consensusBuy — 2.1 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range60% of the way from its 52-week low to high
Price targetAvg target +16% vs current price
Analyst price target
~12-month · 8 analysts$118.75average target+16.1% vs now
Now $102.30
Low $102.00High $135.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.34B
52-wk high
$118.01
52-wk low
$79.01
50-day avg
$97.04
200-day avg
$95.29
Trailing P/E
37.6